TABLE 2.
Model results
OCS age 17 | Cannabis age 17 | OCS age 19 | Cannabis age 19 | |
---|---|---|---|---|
Overall sample (N = 547) | ||||
OCS PRS | −0.02 | −0.12** | 0.08* | −0.04 |
OCS age 17 | - | 0.18*** | 0.32*** | −0.03 |
Cannabis age 17 | - | - | 0.13** | 0.53*** |
OCS age 19 | - | - | - | 0.03 |
European American males (n = 120) | ||||
OCS PRS | 0.01 | −0.20* | 0.07 | −0.15+ |
OCS age 17 | - | 0.20* | 0.30** | −0.03 |
Cannabis age 17 | - | - | 0.15 | 0.43*** |
OCS age 19 | - | - | - | −0.03 |
European American females (n = 118) | ||||
OCS PRS | −0.07 | −0.16+ | 0.12 | 0.00 |
OCS age 17 | - | 0.32** | 0.18+ | −0.08 |
Cannabis age 17 | - | - | 0.16 | 0.52*** |
OCS age 19 | - | - | - | 0.03 |
African American males (n = 76) | ||||
OCS PRS | −0.09 | 0.10 | 0.09 | 0.05 |
OCS age 17 | - | 0.04 | 0.30** | −0.01 |
Cannabis age 17 | - | - | 0.26* | 0.69*** |
OCS age 19 | - | - | - | −0.04 |
African American females (n = 96) | ||||
OCS PRS | −0.19+ | −0.06 | −0.01 | 0.03 |
OCS age 17 | - | 0.26* | 0.43*** | 0.05 |
Cannabis age 17 | - | - | 0.04 | 0.57*** |
OCS age 19 | - | - | - | 0.15 |
Abbreviations: OCS, obsessive-compulsive symptoms; PRS, polygenic risk scores.
p < .001;
p < .01;
p < .05.
p < .1.